FDA Issues Warning Letter to Lonza Plant in U.S.

07:19 AM | September 14, 2011 | Deepti Ramesh

The U.S. Food and Drug Administration (FDA) issued a warning letter earlier this month to Lonza’s manufacturing plant at Hopkinton, MA, for deviating from current good manufacturing practice (cGMP)...